The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency.

ABSTRACT:

Background

Intravenous iron allows for efficient and well-tolerated treatment in iron deficiency and is routinely used in diseases of the gastrointestinal tract.

Objective

The aims of this study were to determine the probability of relapse of iron deficiency over time and to investigate treatment routine, effectiveness, and safety of iron isomaltoside.

Methods

A total of 282 patients treated with iron isomaltoside were observed for two treatments or a minimum of one year.

Results

Out of 282 patients, 82 had Crohn's disease and 67 had ulcerative colitis. Another 133 patients had chronic blood loss, malabsorption, or malignancy. Patients who received an iron isomaltoside dose above 1000 mg had a 65% lower probability of needing retreatment compared with those giv

SUBMITTER: Frigstad SO 

PROVIDER: S-EPMC5682076 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature